This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2021
Title: Mamiko Machida: Innovator in Neuroprotective Peptides
Introduction
Mamiko Machida is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of neuroprotective peptides, holding a total of three patents. Her work focuses on developing innovative solutions for neuropathic treatments.
Latest Patents
Mamiko Machida's latest patents include a neuroprotective peptide derived from proline-rich protein 4 (PRP4). This peptide fragment exhibits neuroprotective action and can be utilized as a drug in preventive or alleviative pharmaceutical compositions. Additionally, her patents describe a peptide that serves as a neuroprotective drug and is effective in neuropathic treatment. The peptide comprises proline-rich protein 4 with the sequence of SEQ ID NO:1 or a modified sequence that retains its neuroprotective properties.
Career Highlights
Throughout her career, Mamiko has worked with notable organizations, including Senju Pharmaceutical Co., Ltd. and Kyoto University. Her research and innovations have garnered attention in the scientific community, contributing to advancements in neuroprotection.
Collaborations
Mamiko has collaborated with esteemed colleagues such as Takeshi Nakajima and Yujiro Hayashi. These partnerships have further enhanced her research and development efforts in the field of neuroprotective peptides.
Conclusion
Mamiko Machida is a trailblazer in the development of neuroprotective peptides, with a focus on creating effective treatments for neuropathic conditions. Her innovative work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile